GIAMPIETRO, OTTAVIO
 Distribuzione geografica
Continente #
NA - Nord America 19.937
AS - Asia 13.221
EU - Europa 8.634
SA - Sud America 1.301
AF - Africa 281
Continente sconosciuto - Info sul continente non disponibili 155
OC - Oceania 27
Totale 43.556
Nazione #
US - Stati Uniti d'America 19.148
CN - Cina 4.258
SG - Singapore 4.234
IT - Italia 2.533
HK - Hong Kong 1.778
SE - Svezia 1.416
BR - Brasile 1.075
BG - Bulgaria 904
KR - Corea 850
VN - Vietnam 736
UA - Ucraina 677
CA - Canada 666
TR - Turchia 601
FI - Finlandia 591
DE - Germania 561
FR - Francia 545
GB - Regno Unito 473
RU - Federazione Russa 367
CH - Svizzera 295
IN - India 195
JP - Giappone 165
CI - Costa d'Avorio 130
BD - Bangladesh 91
AR - Argentina 76
BE - Belgio 58
MX - Messico 51
ID - Indonesia 39
IQ - Iraq 38
ZA - Sudafrica 36
PK - Pakistan 32
NL - Olanda 31
SA - Arabia Saudita 31
CO - Colombia 30
AT - Austria 29
VE - Venezuela 29
EC - Ecuador 28
ES - Italia 23
PL - Polonia 23
IL - Israele 21
AU - Australia 19
UZ - Uzbekistan 19
CZ - Repubblica Ceca 18
JO - Giordania 17
MA - Marocco 17
PE - Perù 16
CL - Cile 15
IE - Irlanda 15
JM - Giamaica 15
KE - Kenya 15
SN - Senegal 15
AE - Emirati Arabi Uniti 13
KZ - Kazakistan 13
MY - Malesia 12
NP - Nepal 12
BJ - Benin 11
BO - Bolivia 11
EG - Egitto 11
HU - Ungheria 11
TN - Tunisia 11
UY - Uruguay 11
HN - Honduras 10
DK - Danimarca 9
LT - Lituania 9
NG - Nigeria 9
PH - Filippine 9
RO - Romania 9
TT - Trinidad e Tobago 9
AL - Albania 8
CR - Costa Rica 8
GR - Grecia 8
PY - Paraguay 8
NZ - Nuova Zelanda 7
PS - Palestinian Territory 7
BB - Barbados 6
DZ - Algeria 6
LB - Libano 6
OM - Oman 6
AZ - Azerbaigian 5
RS - Serbia 5
ET - Etiopia 4
GT - Guatemala 4
AO - Angola 3
DO - Repubblica Dominicana 3
EE - Estonia 3
EU - Europa 3
IR - Iran 3
KW - Kuwait 3
LK - Sri Lanka 3
MO - Macao, regione amministrativa speciale della Cina 3
NI - Nicaragua 3
NO - Norvegia 3
SY - Repubblica araba siriana 3
AM - Armenia 2
BH - Bahrain 2
BS - Bahamas 2
CG - Congo 2
GH - Ghana 2
GY - Guiana 2
HT - Haiti 2
LU - Lussemburgo 2
Totale 43.362
Città #
Singapore 2.474
Ashburn 2.349
Chandler 1.791
Hong Kong 1.763
Hefei 1.221
Fairfield 1.204
San Jose 1.146
Dallas 1.104
Milan 989
Sofia 902
Jacksonville 890
Seoul 844
Woodbridge 818
Santa Clara 785
Beijing 702
Ann Arbor 679
Houston 640
Shanghai 616
Ottawa 576
Seattle 559
New York 540
Wilmington 481
Princeton 397
Izmir 387
Boardman 385
Cambridge 379
Lawrence 348
Nanjing 325
Des Moines 310
Lauterbourg 305
Bern 288
Medford 286
Los Angeles 224
Council Bluffs 213
Dearborn 201
Istanbul 173
Tokyo 158
Jüchen 157
Dong Ket 150
Buffalo 146
Ho Chi Minh City 135
Nanchang 134
Marseille 133
Abidjan 130
Helsinki 112
Hanoi 107
Florence 106
Frankfurt am Main 97
Redondo Beach 91
Kunming 90
San Diego 78
São Paulo 78
Rome 70
Boulder 67
The Dalles 67
Pune 66
Tianjin 66
Redwood City 60
Ogden 59
Columbus 56
Brussels 55
Changsha 55
Shenyang 47
Chicago 44
Hebei 42
London 42
Jiaxing 39
Rio de Janeiro 37
Orem 36
Norwalk 33
Verona 32
Falls Church 31
Guangzhou 30
Orange 30
Chennai 29
Munich 29
Detroit 28
Jinan 27
Phoenix 27
Serra 27
Brooklyn 26
Da Nang 25
Nuremberg 25
Hangzhou 24
Manchester 21
Auburn Hills 20
Belo Horizonte 20
Edinburgh 20
Johannesburg 20
Lancaster 20
Porto Alegre 20
Toronto 20
Vienna 20
Warsaw 20
Brasília 19
Düsseldorf 19
San Francisco 19
Atlanta 18
Jakarta 18
Lanzhou 18
Totale 30.839
Nome #
Nonenzymatic glycation of human platelet membrane proteins in vitro and in vivo. 325
H emodynamic and metabolic correlates of microalbuminuria and erytrocyte Na/H exchange in Hypertension. 29th annual meting of the E.S.C.I. Cambridge 2and-5th April 1995. 296
CardioChek PA cholesterol-testing device compared to diagnostic laboratory method 280
Study of skin vasomotion in type 1 diabetic patients and of its possible relationship with clinical and laboratory variables 238
Improving CardioCheck PA analytical performance: three-year study. 212
Albuminuria and endothelial dysfunction in hypertensive subjects 208
Epidemiology of cardiovascular disease in patients with type 1 diabetes: European perspective. 208
Valutazione dell'asse ipotalamo-ipofisi-gonadi nel maschio diabetico. 207
Short-term vs. overnight urine collection for screening of urinary albumin excretion rate. 207
Su di un caso di galattorrea normoprolattinemica in una donna fertile portatrice di un contraccettivo a base di rame (copper intrauterine device, copper IUD). 206
Pregnancy induction after bromocriptine-cyclofenil treatment in some normoprolactinemic anovulatory women. 196
Can Mediterranean Diet Counteract Metabolic Syndrome Diffusion? 196
Macro-creatine kinase isoenzyme (Macro-CK), a macromolecular form of a tumor-associated marker (CK-BB), in hypothyroidism. 193
Glycosylated LDL analyzed by electrophoretic mobility (E.M.). 192
Evidence indirectly confirming that plasma glucose decreases on storage at -20 degrees C. 191
Colorimetric versus radioimmunological measurement of glycated and non-glycated serum albumin after affinity chromatography. 190
An optimized method to measure glycosylproteins: HPLC assay of 5-hydroxymethil-2-furfuraldehyde (5-HMF). 189
Diagnosi precoce della nefropatia diabetica: risultati clinico-epidemiologici, aspetti fisiopatologici, ipotesi di lavoro. 188
Microalbuminuria and endothelial dysfunction in essential hypertension. 187
MICROALBUMINURIA IN TYPE-I (INSULIN-DEPENDENT) DIABETIC-PATIENTS WITH AND WITHOUT RETINOPATHY 186
Altered Proportions of Naïve, Central Memory and Terminally Differentiated Central Memory Subsets among CD4(+) and CD8 (+) T Cells Expressing CD26 in Patients with Type 1 Diabetes. 185
Enzimuria e tubulopatia diabetica: più di un semplice sospetto. 183
PREVALENCE AND TYPE OF SEXUAL DYSFUNCTIONS IN DIABETIC MALES - A STANDARDIZED CLINICAL APPROACH 183
Microalbuminuria and Erythrocyte Na+/H+ Exchange in Hypertension. Hemodynamic and Metabolic correlates. 183
Peripheral microvascular dysfunction as an independent predictor of atherosclerotic damage in type 1 diabetes patients: A preliminary study. 183
Basal insulin kinetics and glucose-stimulated secretion in untreated and treated diabetic patients and in normal subjects. 182
Circadian Rhythm of Blood Pressure in Diabetes Mellitus: Evidence, Mechanisms and Implications. 179
Valutazione del grado di conoscenza basale della malattia diabetica in pazienti ambulatoriali. 178
Circulating lipid levels and severity of diabetic retinopathy in type I diabetes mellitus. 178
Dosaggio radioimmunologico della insulina plasmatica nella malattia diabetica. 177
FACTORS AFFECTING SERUM MYOGLOBIN LEVELS IN NORMAL POPULATION 177
Which method for 'microalbuminuria' in diabetes mellitus? 177
Terapia dell' infertilita' femminile normoprolattinemica: uso ed efficacia dell' associazione ciclofenile-bromocriptina (CB-154). 176
Diabete ed educazione: ruolo ed utilità clinica dell'educazione formale 176
Circulating levels of myoglobin and muscle enzymes in uremics on regular dialytic treatment (RDT): effect of the single dialysis. 175
A protocol for the study of the effects of Glipizide on insulin metabolism in diabetic patients. 173
About CD26high CD8+ lymphocytes in type 1 diabetes mellitus. 171
Peripheral microvascular dysfunction as an independent predictor of atherosclerotic damage in type 1 diabetes patients: A preliminary study. 171
Preliminary results of pregnancy induction with drug combination cyclofenilbromocriptine. 170
Aggregazione familiare di fattori di rischio cardiovascolare e di indicatori di disfunzione renale nel diabete mellito tipo 1. 170
Dissociation between albuminuria and insulinaemia in hypertensive and atherosclerotic men 170
Improving CardioChek PA analytical performance: three-year study. 170
Metabolic control affects plasma lipid and apolipoprotein levels in women, but not in men, with IDDM 169
Severe leukopenia and mild thrombocytopenia after chronic bromocriptine (CB-154) administration. 168
Statin intolerance: why and what to do - with a focus on diabetic people. 168
Knowledge on diabetes and performance among health professionals in non-diabetological departments. 167
Unusual prolactin response to luteinizing hormone-releasing hormone in some anovulatory women. 166
Behavior of blood prolactin in secondary amenorrhea and in menstrual cycle disorders after gonadotropin releasing hormone and TRH administration. 165
Exercise-induced proteinuria in well-trained athletes. 165
Measurement of ATPases in red cells: setting up and validation of a highly reproducible method. 165
Terapia combinata bromocriptina-antiestrogeni (clomifene o ciclofenile) nella anovulatorieta' normoprolattinemica e nella oligospermia idiopatica. 163
Effects of guar-pasta on serum lipid levels in obese diabetic and non-diabetic women with normal lipids. 163
Four methods for glucose assay compared for various glucose concentrations and under different clinical conditions. 162
Factitious hypoglycemia in an insulin-dependent woman in the eighth week of gestation 162
Comportamento della prolattina nelle amenorree secondarie e nei disordini del ciclo mestruale dopo GNRH e TRH. 161
Epidemiology of diabetic nephropathy in Europe 161
High rate of conception by cyclophenil-bromocryptine regimen in infertile women with normal prolactin levels. 160
Microalbuminuria in diabetes: which method to employ, which sample to collect. 160
Microalbuminuria in diabetes mellitus: more on urine storage and accuracy of colorimetric assays. 159
Prevalence of hypertension and microalbuminuria in adult type 1 (insulin-dependent) diabetic patients without renal failure in Italy. I. Validation of screening techniques to detect microalbuminuria. 159
Guar-pasta: a new diet for obese subjects? 159
Antiproliferative properties of bromocryptine (CB-154) on human cells: a further rationale for medical management of pituitary macroadenomas. 158
'Microalbuminuria' in type I (insulin-dependent) diabetic patients with and without retinopathy. 158
Iperprolattinemia "fasica" dopo LHRH nelle pazienti anovulatorie e sua terapia con bromocriptina (CB-154). 157
Microalbuminuria and endothelial dysfunction in essential hypertension 157
Macro serum CK-BB in a woman with severe primary hypothyroidism. 155
Albuminuria estimated from proteinuria in diabetics. Is it a real alternative in clinical practice? 155
Erithrocyte-antiport activity in hypertensive patients and cardiac hypertrophy. 28th Annual Meeting of the European Society for Clinical Investigation , Toledo, April 20-23, 1994 155
Terapia dell'infertilità normoprolattinemica nella donna e nell'uomo mediante l'associazione bromocriptina-antiestrogeni. 154
Orlistat a basse dosi (60 mg due volte/die) in obesi con sindrome metabolica: non solo perdita di peso. 154
ALBUMINURIA AND ENDOTHELIAL DYSFUNCTION IN HYPERTENSIVE SUBJECTS 153
Risposta del GH al GHRH, alla clonidina ed al TRH nel diabete mellito tipo I. 152
Effects of tiadenolo on hypercholesterolemic diabetic and non-diabetic patients. 152
Microalbuminuria is linked with abnormalities favoring atherosclerosis in type 2 diabetics. 152
Anthropometric indices of school children and familiar risk factors. 151
Point-of-care testing for the sceening of dyslipidaemia: final results of a three-year independent evaluation protocol. 151
Abnormal circulating levels of muscle enzymes and myoglobin in hypothyroidism: their significance and usefulness in follow-up of replacement therapy of the metabolic disorder 150
Evidenza clinica e sperimentale dell'attivita' antimitotica della bromocriptina (CB-154). 150
Relation between microalbuminuria and diabetic retinopathy. 150
Il piede diabetico: diagnosi e terapia. 149
Measurable deficit of autonomic and sensory nerve function in asymptomatic diabetic patients. 149
Ultrasonic myocardial texture and hyperinsulinemia in essential hypertension. 149
Bromocryptine-cyclofenil associated therapy: an effective and safe mode of treatment of female normoprolactinemic infertility. 148
Amplitude loss of electrically and magnetically evoked sympathetic skin responses in early stages of type 1 (insulin-dependent) diabetes mellitus without signs of dysautonomia. 148
A sensitive high performance liquid chromatographic method for determining small amounts of glycosylproteins. 147
More on effects of storage time and temperature on measurement of small concentrations of albumin in urine. 147
Ambulatory blood pressure monitoring and circadian rhythm of blood pressure in diabetes mellitus. 147
Female normoprolactinaemic infertility: a poorly defined clinical disturbance, a possible physiopathological mechanism, an effective regimen therapy. 146
Validazione di due reflettometri di recente introduzione sul mercato per la determinazione della glicemia. 146
Imipenem/cilastatin reduces cyclosporin-induced tubular damage in kidney transplant recipients 146
Radioimmunological measurement of urinary albumin in diabetic patients and in normal subjects. 145
How and how long to store urine samples before albumin radioimmunoassay: a practical response. 145
Excretion of digoxin-like immunoreactivity in urine of normal subjects: correlations with excretion of creatinine and electrolytes. 144
More on effects of storage time and temperature on urinary enzymes: a 1-year study. 144
Erythrocyte Na+/H+ exchange and preclinical abnormalities of the left ventricular diastolic function in normotensive type 1 (insulin-dependent) diabetic patients. 144
Increased echodensity of myocardial wall in the diabetic heart: an ultrasound tissue characterization study. 144
Regulatory T cells with effector memory phenotype and glycaemic control in type 1 diabetes mellitus. 144
Asymptomatic bacteriuria in women with diabetes: influence of metabolic control 143
Circadian Blood pressure variability in type 1 diabetes subjects and their nondiabetic siblings – influence of erythrocyte electron transfer 143
Radioimmunological determination of the MB-isoenzyme of creatine-phosphokinase: comparison with immuno-enzymatic procedures. 142
Totale 17.108
Categoria #
all - tutte 125.341
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 125.341


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20223.415 0 253 44 307 642 467 44 211 161 64 116 1.106
2022/20234.261 540 412 197 396 530 666 44 348 770 17 312 29
2023/20243.782 686 355 523 209 504 570 103 402 73 32 39 286
2024/20259.315 39 411 94 563 614 731 602 548 938 1.297 1.438 2.040
2025/20269.842 748 1.967 1.312 654 708 1.075 1.789 296 349 626 197 121
2026/2027370 264 106 0 0 0 0 0 0 0 0 0 0
Totale 43.556